Reduction of Adhesion Formation by Intraperitoneal Administration of Various Anti-Inflammatory Agents

References

• diZerega G., Rodgers KE. Intraperitoneal adhesions. The Peritoneum. Springer-Verlag, New York 1992; 274–306
   Google Scholar
• Thorton M., diZerega GS. Use of barriers in adhesion prevention. Contemp. OBIGYN. 1996; 41: 201–214
   Google Scholar
• Ellis H. Intestinal Obstruction. Appleton-Century-Crofts, New York 1982
   Google Scholar
• Menzies D. Peritoneal adhesions—incidence, cause, and prevention. Surg Annu. 1992; 24: 27–45
   PubMedGoogle Scholar
• Menzies D., Ellis H. Intestinal obstruction from adhesions — How big is the problem?. Ann R Coll Surg Engl. 1990; 72: 62–63
   Google Scholar
• De Cherney A. H., diZerega GS. Clinical problems intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am. 1997; 77: 671–688
   PubMed Web of Science ®Google Scholar
• Scott DM Coombes, Vipond M. N., Thompson JN. General Surgeon's attitude to the treatment and prevention of abdominal adhesions. Ann R Coll Surg Engl. 1993; 75: 123–128
   PubMedGoogle Scholar
• Blanco J. Bowel obstruction related to prior gynecologic surgery. Pelvic Surgery—Adhesion Formation and Prevention. Springer-Verlag, New York 1997; 160
   Google Scholar
• Federmann G., Walenzyk J., Schneider A., Scheele C., Bauermeister G. Efficacy of laparoscopy in treatment of acute small bowel obstruction caused by adhesions. Peritoneal Adhesions. Springer-Verlag, New York 1997; 291
   Google Scholar
• Treutner K. H., Bertram P., Latzsch G., Schumpelick V. Causes of interstinal obstruction—A retrospective study of 550 surgical cases. Peritioneal Adhesions, KH Treutner, V. Schumpelick. Springer-Verlag, New York 1997; 1991
   Google Scholar
• Schoffel U., Sendt W., Haring R., Fathmann E. H. Indications and therapeutic strategy for intestinal obstruction due to intra-abdominal adhesions. Peritoneal Adhesions, KH Treutner, V. Schumpelick. Springer-Verlag, New York 1997; 271
   Google Scholar
• Ratcliff J. B., Kapernick P., Brook G. G., et al. Small bowel obstruction of gynecologic surgery. South Med J. 1983; 76: 1349–1360
   PubMedGoogle Scholar
• Strickler B., Blanco J., Fox HE. The gynecologic contribution to intestinal obstruction in females. J Am Coll Surg. 1994; 178: 617
   PubMedGoogle Scholar
• Stout A. L., Steege J. F., Dodson W. C., Hughes C. L. Relationship of laparoscopic findings to self-report of pelvic pain. Am J Obstet Gynecol. 1991; 146: 73
   Google Scholar
• Howard F. M. The role of laparoscopy in chronic pelvic pain: Promise and pitfalls. Obstet Gynecol Surv. 1993; 48: 357
   PubMedGoogle Scholar
• Peters AAW, Trimbos-Kemper TCM, Admiraal C., et al. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol. 1992; 99: 59
   PubMedGoogle Scholar
• De Cherney A. H., Mezer HC. The nature of post-tuboplasty pelvic adhesions determined by early and late laparoscopy. Fertil Steril. 1984; 41: 643
   PubMedGoogle Scholar
• Trimbos-Kemper TCM, Trimbos J. B., van Hall EV. Adhesion formation after tubal surgery results of the eight-day laparoscopy in 188 patients. Fertil Steril. 1985; 43: 396
   Google Scholar
• Duffy D. M., diZerega GS. Is peritoneal closure necessary?. Obstet Gynecol Surv. 1994; 49: 817–822
   PubMedGoogle Scholar
• Marana R., Rizzi M., Ludovico M. Adhesions and infertility. Pelvic Surgery—Adhesion Formation and Prevention, GS diZerega, AH De Chevney, MP Diamond, RC Dunn, EP Goldberg, AF Haney, JA Rock, T. Tulandis, KE Rodgers. Springer-Verlag, New York 1997; 126
   Google Scholar
• Lundorff P. infertility and ectopic pregnancy. Pelvic Surgery—Adhesion Formation and Prevention, GS diZerega, AH De Chevney, MP Diamond, RC Dunn, EP Goldberg, AF Haney, JA Rock, T. Tulandis, KE Rodgers. Springer-Verlag, New York 1997; 144
   Google Scholar
• Bakkum E., Peters AAW. Clinical significance of adhesion in patients with chronic pelvic pain. Pelvic Surgery—Adhesion Formation and Prevention, GS diZerega, AH De Chevney, MP Diamond, RC Dunn, EP Goldberg, AF Haney, JA Rock, T. Tulandis, KE Rodgers. Springer-Verlag, New York 1997; 150
   Google Scholar
• diZerega G., Rodgers KE. Prevention of postoperative adhesions. The Peritoneum. Springer-Verlag, New York 1992; 307–370
   Google Scholar
• diZerega G. S. Contemporary adhesion prevention. Fertil Steril. 1994; 61: 219–235
   PubMed Web of Science ®Google Scholar
• Adhesion Study Group. Reduction of post operative pelvic adhesions with intraperitoneal 32% dextran 70: A prospective, randomized clinical trial. Fertil Steril. 1983; 40: 612–619
   PubMed Web of Science ®Google Scholar
• Thornton M. H., Campeau J. D., diZerega GS. Use of adhesion prevention barriers in gynecological surgery. Peritoneal Adhesions, KH Treutner, V. Schumpelick. Springer-Verlag, New York 1997; 370
   Google Scholar
• diZerega G. S. Use of adhesion prevention barriers in pelvic reconstructive and gynecologic surgery. Pelvic Surgery—Adhesion Formation and Prevention, GS diZerega, AH De Chevney, MP Diamond, RC Dunn, EP Goldberg, AF Haney, JA Rock, T. Tulandis, KE Rodgers. Springer-Verlag, New York 1997; 188
   Google Scholar
• diZerega G. S. Use of adhesion prevetion barriers in ovarian surgery tubalplasty ectopic pregnancy, endometriosis, adhesiolysis, and myomectomy. Curr iOpin Obstet Gynecol. 1996; 8: 230–237
   PubMed Web of Science ®Google Scholar
• Treutner K. H., Bertram P., Loser S., et al. Prophylaxe und Therapie intraabdomineller adhasionen—Eine umfrage an 1200 Kliniken in Deutschland. Chirurg. 1995; 66: 398–403
   PubMedGoogle Scholar
• Rodgers K. E., Bracken K., Cox G., Richer L., Girgis W., diZerega GS. Inhibition of post surgical adhesions by liposomes containing anti-inflammatory drugs. Int J Fertil. 1990; 35(5)315
   PubMedGoogle Scholar
• Rodgers K., Girgis W., Johns D., di Zerega G. Intraperitoneal tolmetin prevents postsurgical adhesion formation in rabbits. Int J Infertil. 1990; 35: 40–45
   PubMedGoogle Scholar
• Rodgers K. E., Ellefson D. D., Girgis W., diZerega G. S. Modulation of postsurgical cell infiltration and fibriolytic activity by tolmetin in two species. J Surg Res. 1994; 56: 314–325
   PubMedGoogle Scholar
• LeGrand E. K., Rodgers K. E., Girgis W., Campeau J. D., diZerega GS. Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion prevention model. I Invest Surg. 1995; 8: 187–194
   PubMed Web of Science ®Google Scholar
• Rodgers K. E., Girgis W., Campeau J. D., diZerega G. S. Reduction of adhesion formation by intraperitoneal administration of a recombinant hirudin analog. J Invest Surg. 1996; 9: 388–391
   Google Scholar
• Rodgers K. E., Girgis W., Campeau J. D., diZerega G. S. Reduction of adhesion formantion by intraperitoneal administration of anti-inflammatory peptide 2. I Invest Surg. 1997; 10: 31–36
   PubMed Web of Science ®Google Scholar
• Rodgers K. E., Johns D., diZerega GS. Prevention of adhesion formation after intraperitoneal administration of tolmetin and hyaluronic acid. J Invest Surg., in press
   Google Scholar
• Mehta K., McQueen T., Tucker S., Pandita R., Aggarwal BB. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J leukocyte Biol. 1994; 44: 336–342
   Google Scholar
• Olansky A. J. Antimalarials and ophthalmologic safety. J Am Acad Dermatol. 1982; 6: 19–23
   PubMed Web of Science ®Google Scholar
• Fitch C. D. Mode of action of antimalarial drugs. CIBA Foundation Symp. 1983; 94: 222–232
   PubMedGoogle Scholar
• Beckman A., Seferynska F. Possible involvement of phospholipase activation in erythroid progenitor cell proliferation. Exp Hematol. 1989; 17: 309–312
   PubMedGoogle Scholar
• White S. R., Strek M. E., Kulp G. V., Spaethe S. M., Burch R. A., Neeley S. P., Leff AR. Regulation of human eosinophil de-granulation and activation by endogenous phospholipase A2. J Clin Invest. 1993; 91: 2118–2125
   PubMedGoogle Scholar
• Stacey N. H., Klaassen CD. Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolate rat hepatocytes. J Toxicol Environ Health. 1982; 9: 439–450
   PubMed Web of Science ®Google Scholar
• O'Rourke A. M., Mescher M. F., Apgar JR. IgE receptor-mediated arachidonic acid release by rat basophilic leukemia(RBL-2H3) cells: Possible role in activating de-granulation. Mol Immunol. 1992; 29: 1299–1308
   PubMed Web of Science ®Google Scholar
• Randall R. W., Eakins K. E., Higgs GA. Inhibition of arachidonic acid cyclooxygenase and lipooxygenase activities by indomethacin and compound BW755. Agents Actions 1980; 10: 553–555
   PubMedGoogle Scholar
• Golan A., Stolik O., Wexler S., Lander R., Ber A., David MP. Prostaglandins—A role in adhesion formation. An experimental study. Acta Obstet Gynecol Scand. 1990; 69: 339–341
   PubMed Web of Science ®Google Scholar
• Golan A., Bernstein T., Wexler S., Neuman M., Bukovsky I., David MP. The effect of prostaglandins and aspirin: An inhibitor of prostaglandin synthesis on adhesion formation in rats. Human Reprod., 6: 251–254
   PubMedGoogle Scholar
• Mammen EF. An overview of dipyridamole. Thromb Res Suppl. 1990; XIII: 1–10
   Google Scholar
• Boeynaems J. M., Van-Coevorden A., De molle D. Dipyridamole and vascular prostacyclin production. Biochem Pharmacol. 1986; 35: 2897
   PubMedGoogle Scholar
• Tzanakakis G. N., Agarwal K. C., Vezeredis MP. Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233. Cancer 1993; 71: 2466
   PubMed Web of Science ®Google Scholar
• Constantini V., Talpacci A., Bastino M. L., Boschetti E., Cipolloni S., Bisacci R., Nenci GG. Increased prostacyclin production from human veins by dipyridamole: An in vitro and ex vitro study. Biomed Biochim Acta. 1991; 49: 263
   Google Scholar
• Nishimura K., Shimanuki T., diZerega GS. The use of ibuprofen for the prevention of postoperative adhesions in rabbits. Am J Med. 1984; 77: 102–106
   PubMedGoogle Scholar
• Zitnik RM Kotloff, Latifpour J., Schwalb J., Zheng T., Whiting N. L., Elias JA. Retinoic acid inhibition of IL-1 induced IL-6 production by human lung fibroblasts. J Immunol. 1994; 152: 1419–1427
   PubMed Web of Science ®Google Scholar
• Schuster P. A., Medcalf R. L., Kruithof EKO. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Endocrinology 1993; 133: 1724–1730
   PubMedGoogle Scholar
• Immonen R., Siren V., Stephens R. W., Liesto K., Vaheri A. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture. Invest Ophthal Visual Sci. 1993; 34: 2062–2067
   PubMedGoogle Scholar
• van Giezen JJJ, Boon GIA, Jansen JWCM, Bouma BN. Retinoic acid enhances fibrinolytic activity in vivo by enhancing tissue type plasminogen activator(tPA) activity and inhibits venous thrombosis. Thromb Haemostasis 1993; 69: 381–386
   PubMedGoogle Scholar
• Medh R. D., Santell L., Levin EG. Stimulation of tissue plasminogen activator production by retinoic acid: Synergistic effect on protein kinase C-mediated activation. Blood. 1992; 80(4)981–987
   PubMedGoogle Scholar
• Van Bennekum AM, Emeis J. J., Kooistra T., Hendriks HF. Modulation of tissue type plasminogen activator by retinoids in rat plasma and tissues. Am J Physiol. 1993; 264(5)R931–R937
   Google Scholar
• Conese M., Montemurro P., Fumarulo R., Giordano D., Riccardi S., Colucci M., Semeraro N. Inhibitory effects of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes. Thromb Haemostasis 1991; 66: 662–665
   PubMedGoogle Scholar
• Horie S., Kizaki K., Ishii H., Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Biochem J. 1993; 281: 149–154
   Google Scholar
• Ishii H., Horie S., Kizaki K., Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in human endothelial cells exposed to tumor necrosis factor. Blood. 1992; 80: 2556–2562
   PubMed Web of Science ®Google Scholar
• Mumford D., Kessel SJ. Sterilization needs in the 1990s: The case for quinacrine nonsurgical female sterilization. Am J Obstet Gynecol. 1992; 167: 1203–1207
   PubMed Web of Science ®Google Scholar
• Moreno J. J., Ferrer X., Ortega E., Carganico G. PLA2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action. Agents Actions 1992; 36: 258–263
   PubMedGoogle Scholar
• Foeldes A. J., Filep RE. Mepacrine inhibits fMLP-induced activation of human neutrophil granulocytes, leukotrienes B4 formation and fMLP binding. J Leukocyte Biol. 1992; 52: 545–550
   PubMedGoogle Scholar
• Prowse C., Pepper D., Dawes J. Prevention of the platelet alpha-granule reaction by membrane active drugs. Thromb Res 1982; 25: 219–227
   PubMed Web of Science ®Google Scholar
• Raftery A. T. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. Eur Surg Res. 1981; 13: 397–401
   PubMed Web of Science ®Google Scholar
• Buckman R. F., Buckman P. D., Hufnagel H. V., Gervin A. S. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res. 1976; 21: 67–76
   PubMed Web of Science ®Google Scholar
• Saniabadi A. R., Fisher T. C., McLaren M., Belch J. F., Forbes CD. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGl2 generation, and red cell deformability ex vivo in man. Cardiovasc Res. 1991; 25: 177
   PubMed Web of Science ®Google Scholar
• Gryglewski R. J. Prostaglandins, platelets, and atherosclerosis. CRC Crit Rev Biochem. 1980; 7(4)291–338
   PubMed Web of Science ®Google Scholar
• Hasday J. D., Sitrin RJ. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: A possible mechanism of antithrombotic action. Blood. 1987; 69: 660
   PubMed Web of Science ®Google Scholar
• Colli S., Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: Adenosine-dependent and adenosine-independent mechanisms. J Lab Clin Med. 1991; 118: 126
   Google Scholar
• Aznar-Salatti J., Bastida E., Escolar G., Almirall L., Diaz-Ricart M., Anton P., Castillo R., Ordinas A. Dipyridamole induces changes in the thrombogenic properties of extracellular matrix produced by endothelial cell in culture. Thromb Res. 1991; 64: 341
   PubMedGoogle Scholar
• LeVraux V., et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci. 1993; 52: 1917
   PubMedGoogle Scholar
• Bronza J. P., et al. Dipyridamole inhibits superoxide anion release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide. Thromb Res. 1990; 60: 141
   PubMedGoogle Scholar
• Suzuki S., Sugar K., Sato H., Sakatume M., Arakawa M. Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes. Eur J Pharmacol. 1992; 227: 395
   PubMedGoogle Scholar